BPC-157 Tendon Injury Mechanism: Comparison Table
Before using the comparison below, understand that BPC-157's efficacy is mechanism-dependent. It doesn't 'boost healing' generically. It addresses specific molecular bottlenecks that limit tendon repair. Comparing it to passive modalities or systemic anti-infl
This comparison does not assign a generated winner or score.
- Before using the comparison below, understand that BPC-157's efficacy is mechanism-dependent. It doesn't 'boost healing' generically. It addresses specific molecular bottlenecks that limit tendon repair. Comparing it to passive modalities or systemic anti-inflammatories clarifies why timing and co-interventions matter.
- BPC-157 (subcutaneous)
- VEGF upregulation, FAK-paxillin activation, FGF-2 signaling
- 340% increase in capillary density by day 10
- 70–80% baseline by day 14
- 85–92% with structured loading
- Most direct biological intervention for hypovascular tendon tissue. Addresses root cause of delayed healing
- Platelet-Rich Plasma (PRP)
- Growth factor release from alpha granules
- Moderate. Dependent on platelet concentration
- 50–60% baseline by day 14
- 70–80%
- Effective but variable. Quality depends on preparation protocol and baseline platelet count
- NSAIDs (ibuprofen, naproxen)
- COX inhibition, reduced prostaglandin synthesis
- None. May impair angiogenesis
- Delayed. Anti-inflammatory effect suppresses early fibroblast activity
- 55–65%
- Reduces pain but delays structural recovery. Contraindicated during proliferation phase
- Physical therapy alone
- Mechanical loading, eccentric exercise
- Indirect. Shear stress upregulates VEGF modestly
- 40–50% baseline by day 14
- 60–70%
- Essential for remodeling but insufficient without vascular support during proliferation
- Corticosteroid injection
- Glucocorticoid receptor activation, broad immunosuppression
- Suppressed. Inhibits VEGF expression
- Suppressed. Collagen synthesis inhibited for 2–4 weeks post-injection
- 40–55%
- Short-term pain relief but long-term structural harm. Avoid during active recovery